BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 34758253)

  • 21. Artificial intelligence enables comprehensive genome interpretation and nomination of candidate diagnoses for rare genetic diseases.
    De La Vega FM; Chowdhury S; Moore B; Frise E; McCarthy J; Hernandez EJ; Wong T; James K; Guidugli L; Agrawal PB; Genetti CA; Brownstein CA; Beggs AH; Löscher BS; Franke A; Boone B; Levy SE; Õunap K; Pajusalu S; Huentelman M; Ramsey K; Naymik M; Narayanan V; Veeraraghavan N; Billings P; Reese MG; Yandell M; Kingsmore SF
    Genome Med; 2021 Oct; 13(1):153. PubMed ID: 34645491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic yield and clinical utility of whole exome sequencing using an automated variant prioritization system, EVIDENCE.
    Seo GH; Kim T; Choi IH; Park JY; Lee J; Kim S; Won DG; Oh A; Lee Y; Choi J; Lee H; Kang HG; Cho HY; Cho MH; Kim YJ; Yoon YH; Eun BL; Desnick RJ; Keum C; Lee BH
    Clin Genet; 2020 Dec; 98(6):562-570. PubMed ID: 32901917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specialist multidisciplinary input maximises rare disease diagnoses from whole genome sequencing.
    Macken WL; Falabella M; McKittrick C; Pizzamiglio C; Ellmers R; Eggleton K; Woodward CE; Patel Y; Labrum R; ; Phadke R; Reilly MM; DeVile C; Sarkozy A; Footitt E; Davison J; Rahman S; Houlden H; Bugiardini E; Quinlivan R; Hanna MG; Vandrovcova J; Pitceathly RDS
    Nat Commun; 2022 Nov; 13(1):6324. PubMed ID: 36344503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Limitations of exome sequencing in detecting rare and undiagnosed diseases.
    Burdick KJ; Cogan JD; Rives LC; Robertson AK; Koziura ME; Brokamp E; Duncan L; Hannig V; Pfotenhauer J; Vanzo R; Paul MS; Bican A; Morgan T; Duis J; Newman JH; Hamid R; Phillips JA;
    Am J Med Genet A; 2020 Jun; 182(6):1400-1406. PubMed ID: 32190976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Young people's understanding, attitudes and involvement in decision-making about genome sequencing for rare diseases: A qualitative study with participants in the UK 100, 000 Genomes Project.
    Lewis C; Hammond J; Hill M; Searle B; Hunter A; Patch C; Chitty LS; Sanderson SC
    Eur J Med Genet; 2020 Nov; 63(11):104043. PubMed ID: 32835846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Whole-genome sequencing of patients with rare diseases in a national health system.
    Turro E; Astle WJ; Megy K; Gräf S; Greene D; Shamardina O; Allen HL; Sanchis-Juan A; Frontini M; Thys C; Stephens J; Mapeta R; Burren OS; Downes K; Haimel M; Tuna S; Deevi SVV; Aitman TJ; Bennett DL; Calleja P; Carss K; Caulfield MJ; Chinnery PF; Dixon PH; Gale DP; James R; Koziell A; Laffan MA; Levine AP; Maher ER; Markus HS; Morales J; Morrell NW; Mumford AD; Ormondroyd E; Rankin S; Rendon A; Richardson S; Roberts I; Roy NBA; Saleem MA; Smith KGC; Stark H; Tan RYY; Themistocleous AC; Thrasher AJ; Watkins H; Webster AR; Wilkins MR; Williamson C; Whitworth J; Humphray S; Bentley DR; ; Kingston N; Walker N; Bradley JR; Ashford S; Penkett CJ; Freson K; Stirrups KE; Raymond FL; Ouwehand WH
    Nature; 2020 Jul; 583(7814):96-102. PubMed ID: 32581362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of inversions across 33,924 families with rare disease from a national genome sequencing project.
    Pagnamenta AT; Yu J; Walker S; Noble AJ; Lord J; Dutta P; Hashim M; Camps C; Green H; Devaiah S; Nashef L; Parr J; Fratter C; Ibnouf Hussein R; Lindsay SJ; Lalloo F; Banos-Pinero B; Evans D; Mallin L; Waite A; Evans J; Newman A; Allen Z; Perez-Becerril C; Ryan G; Hart R; Taylor J; Bedenham T; Clement E; Blair E; Hay E; Forzano F; Higgs J; Canham N; Majumdar A; McEntagart M; Lahiri N; Stewart H; Smithson S; Calpena E; Jackson A; Banka S; Titheradge H; McGowan R; Rankin J; Shaw-Smith C; Evans DG; Burghel GJ; Smith MJ; Anderson E; Madhu R; Firth H; Ellard S; Brennan P; Anderson C; Taupin D; Rogers MT; Cook JA; Durkie M; East JE; Fowler D; Wilson L; Igbokwe R; Gardham A; Tomlinson I; Baralle D; Uhlig HH; Taylor JC
    Am J Hum Genet; 2024 Jun; 111(6):1140-1164. PubMed ID: 38776926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genome analysis and knowledge-driven variant interpretation with TGex.
    Dahary D; Golan Y; Mazor Y; Zelig O; Barshir R; Twik M; Iny Stein T; Rosner G; Kariv R; Chen F; Zhang Q; Shen Y; Safran M; Lancet D; Fishilevich S
    BMC Med Genomics; 2019 Dec; 12(1):200. PubMed ID: 31888639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CNV Detection from Exome Sequencing Data in Routine Diagnostics of Rare Genetic Disorders: Opportunities and Limitations.
    Royer-Bertrand B; Cisarova K; Niel-Butschi F; Mittaz-Crettol L; Fodstad H; Superti-Furga A
    Genes (Basel); 2021 Sep; 12(9):. PubMed ID: 34573409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic and clinical utility of whole genome sequencing in a cohort of undiagnosed Chinese families with rare diseases.
    Liu HY; Zhou L; Zheng MY; Huang J; Wan S; Zhu A; Zhang M; Dong A; Hou L; Li J; Xu H; Lu B; Lu W; Liu P; Lu Y
    Sci Rep; 2019 Dec; 9(1):19365. PubMed ID: 31852928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH.
    Zhu N; Swietlik EM; Welch CL; Pauciulo MW; Hagen JJ; Zhou X; Guo Y; Karten J; Pandya D; Tilly T; Lutz KA; Martin JM; Treacy CM; Rosenzweig EB; Krishnan U; Coleman AW; Gonzaga-Jauregui C; Lawrie A; Trembath RC; Wilkins MR; ; ; ; ; Morrell NW; Shen Y; Gräf S; Nichols WC; Chung WK
    Genome Med; 2021 May; 13(1):80. PubMed ID: 33971972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The genomic landscape of rare disorders in the Middle East.
    El Naofal M; Ramaswamy S; Alsarhan A; Nugud A; Sarfraz F; Janbaz H; Taylor A; Jain R; Halabi N; Yaslam S; Alfalasi R; Shenbagam S; Rabea F; Bitzan M; Yavuz L; Wafadari D; Abulhoul H; Shankar S; Al Maazmi M; Rizk R; Alloub Z; Elbashir H; Babiker MOE; Chencheri N; AlBanna A; Sultan M; El Bitar M; Kherani S; Thalange N; Alshryda S; Di Donato R; Tzivinikos C; Majid I; Freeman AF; Gonzalez C; Khan AO; Hamdan H; Abuhammour W; AlAwadhi M; AlKhayat A; Alsheikh-Ali A; Abou Tayoun AN
    Genome Med; 2023 Jan; 15(1):5. PubMed ID: 36703223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DIAPH1 Variants in Non-East Asian Patients With Sporadic Moyamoya Disease.
    Kundishora AJ; Peters ST; Pinard A; Duran D; Panchagnula S; Barak T; Miyagishima DF; Dong W; Smith H; Ocken J; Dunbar A; Nelson-Williams C; Haider S; Walker RL; Li B; Zhao H; Thumkeo D; Marlier A; Duy PQ; Diab NS; Reeves BC; Robert SM; Sujijantarat N; Stratman AN; Chen YH; Zhao S; Roszko I; Lu Q; Zhang B; Mane S; Castaldi C; López-Giráldez F; Knight JR; Bamshad MJ; Nickerson DA; Geschwind DH; Chen SL; Storm PB; Diluna ML; Matouk CC; Orbach DB; Alper SL; Smith ER; Lifton RP; Gunel M; Milewicz DM; Jin SC; Kahle KT
    JAMA Neurol; 2021 Aug; 78(8):993-1003. PubMed ID: 34125151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Matching whole genomes to rare genetic disorders: Identification of potential causative variants using phenotype-weighted knowledge in the CAGI SickKids5 clinical genomes challenge.
    Pal LR; Kundu K; Yin Y; Moult J
    Hum Mutat; 2020 Feb; 41(2):347-362. PubMed ID: 31680375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical profiles and diagnostic challenges in 1158 children with rare hepatobiliary disorders.
    Dong Y; Wang J; Zhu S; Zheng H; Wang C; Zhao P
    Pediatr Res; 2021 Jan; 89(1):238-245. PubMed ID: 32289814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exome Sequencing and the Management of Neurometabolic Disorders.
    Tarailo-Graovac M; Shyr C; Ross CJ; Horvath GA; Salvarinova R; Ye XC; Zhang LH; Bhavsar AP; Lee JJ; Drögemöller BI; Abdelsayed M; Alfadhel M; Armstrong L; Baumgartner MR; Burda P; Connolly MB; Cameron J; Demos M; Dewan T; Dionne J; Evans AM; Friedman JM; Garber I; Lewis S; Ling J; Mandal R; Mattman A; McKinnon M; Michoulas A; Metzger D; Ogunbayo OA; Rakic B; Rozmus J; Ruben P; Sayson B; Santra S; Schultz KR; Selby K; Shekel P; Sirrs S; Skrypnyk C; Superti-Furga A; Turvey SE; Van Allen MI; Wishart D; Wu J; Wu J; Zafeiriou D; Kluijtmans L; Wevers RA; Eydoux P; Lehman AM; Vallance H; Stockler-Ipsiroglu S; Sinclair G; Wasserman WW; van Karnebeek CD
    N Engl J Med; 2016 Jun; 374(23):2246-55. PubMed ID: 27276562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exome and genome sequencing in a heterogeneous population of patients with rare disease: Identifying predictors of a diagnosis.
    Pucel J; Briere LC; Reuter C; Gochyyev P; ; LeBlanc K
    Genet Med; 2024 Jun; 26(6):101115. PubMed ID: 38436216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Challenges in the diagnosis and discovery of rare genetic disorders using contemporary sequencing technologies.
    Seaby EG; Ennis S
    Brief Funct Genomics; 2020 Jul; 19(4):243-258. PubMed ID: 32393978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical exome sequencing for genetic identification of rare Mendelian disorders.
    Lee H; Deignan JL; Dorrani N; Strom SP; Kantarci S; Quintero-Rivera F; Das K; Toy T; Harry B; Yourshaw M; Fox M; Fogel BL; Martinez-Agosto JA; Wong DA; Chang VY; Shieh PB; Palmer CG; Dipple KM; Grody WW; Vilain E; Nelson SF
    JAMA; 2014 Nov; 312(18):1880-7. PubMed ID: 25326637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genome Sequencing as a Diagnostic Test in Children With Unexplained Medical Complexity.
    Costain G; Walker S; Marano M; Veenma D; Snell M; Curtis M; Luca S; Buera J; Arje D; Reuter MS; Thiruvahindrapuram B; Trost B; Sung WWL; Yuen RKC; Chitayat D; Mendoza-Londono R; Stavropoulos DJ; Scherer SW; Marshall CR; Cohn RD; Cohen E; Orkin J; Meyn MS; Hayeems RZ
    JAMA Netw Open; 2020 Sep; 3(9):e2018109. PubMed ID: 32960281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.